195 related articles for article (PubMed ID: 30487999)
21. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.
Schoels MM; Aletaha D; Alasti F; Smolen JS
Ann Rheum Dis; 2016 May; 75(5):811-8. PubMed ID: 26269398
[TBL] [Abstract][Full Text] [Related]
22. Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
Coates LC; Nash P; Kvien TK; Gossec L; Mease PJ; Rasouliyan L; Pricop L; Jugl SM; Gandhi KK; Gaillez C; Smolen JS
Semin Arthritis Rheum; 2020 Aug; 50(4):709-718. PubMed ID: 32521325
[TBL] [Abstract][Full Text] [Related]
23. Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal Study.
Hammer HB; Michelsen B; Provan SA; Sexton J; Lampa J; Uhlig T; Kvien TK
Arthritis Care Res (Hoboken); 2020 Jan; 72(1):27-35. PubMed ID: 30474932
[TBL] [Abstract][Full Text] [Related]
24. Residual Disease Activity and Associated Factors in Psoriatic Arthritis.
Lubrano E; Scriffignano S; Perrotta FM
J Rheumatol; 2020 Oct; 47(10):1490-1495. PubMed ID: 31676704
[TBL] [Abstract][Full Text] [Related]
25. Serum Calprotectin as a Promising Inflammatory Biomarker in Psoriatic Arthritis: a 1-Year Longitudinal Study.
Li B; Li G; Song Z; Zhang Z
Rheumatol Ther; 2023 Feb; 10(1):149-160. PubMed ID: 36271188
[TBL] [Abstract][Full Text] [Related]
26. Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia.
Polachek A; Furer V; Zureik M; Nevo S; Mendel L; Levartovsky D; Wollman J; Aloush V; Tzemach R; Elalouf O; Anouk M; Berman M; Kaufman I; Carmi O; Lahat Y; Eviatar T; Padova H; Sarbagil-Maman H; Borok S; Broyde A; Eder L; Paran D; Elkayam O
Ann Rheum Dis; 2021 Dec; 80(12):1553-1558. PubMed ID: 34215648
[TBL] [Abstract][Full Text] [Related]
27. Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients.
Lubrano E; Perrotta FM; Scriffignano S; Coates LC; Helliwell P
Rheumatol Ther; 2019 Dec; 6(4):521-528. PubMed ID: 31428989
[TBL] [Abstract][Full Text] [Related]
28. Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis.
Hammer HB; Michelsen B; Sexton J; Haugen IK; Provan SA; Haavardsholm EA; Uhlig T; Kvien TK
Ann Rheum Dis; 2019 Sep; 78(9):1179-1185. PubMed ID: 31171525
[TBL] [Abstract][Full Text] [Related]
29. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
[TBL] [Abstract][Full Text] [Related]
30. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Gutierrez M
Biomed Res Int; 2014; 2014():528105. PubMed ID: 24967375
[TBL] [Abstract][Full Text] [Related]
31. [A new integral enthesial-comorbididity index of psoriatic arthritis activity].
Korsakova YL; Korotaeva TV; Loginova EY; Gubar EE; Vorobyeva LD; Glukhova SI; Nasonov EL
Ter Arkh; 2023 Jul; 95(5):404-409. PubMed ID: 38158993
[TBL] [Abstract][Full Text] [Related]
32. Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study.
Becciolini A; Parisi S; Del Medico P; Farina A; Visalli E; Molica Colella AB; Lumetti F; Caccavale R; Scolieri P; Andracco R; Girelli F; Bravi E; Colina M; Volpe A; Ianniello A; Ditto MC; Nucera V; Franchina V; Platè I; Donato ED; Amato G; Salvarani C; Bernardi S; Lucchini G; De Lucia F; Molica Colella F; Santilli D; Mansueto N; Ferrero G; Marchetta A; Arrigoni E; Foti R; Sandri G; Bruzzese V; Paroli M; Fusaro E; Ariani A
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36830969
[TBL] [Abstract][Full Text] [Related]
33. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
[TBL] [Abstract][Full Text] [Related]
34. Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists.
Gezer HH; Duruöz MT; Nas K; Kılıç E; Sargın B; Kasman SA; Alkan H; Şahin N; Cengiz G; Cüzdan N; Gezer İA; Keskin D; Mülkoğlu C; Reşorlu H; Sunar İ; Bal A; Küçükakkaş O; Yurdakul OV; Melikoğlu MA; Baykul M; Ayhan FF; Bodur H; Çalış M; Çapkın E; Devrimsel G; Gök K; Hizmetli S; Kamanlı A; Keskin Y; Ecesoy H; Kutluk Ö; Şen N; Şendur ÖF; Tekeoğlu İ; Tolu S; Toprak M; Tuncer T
Joint Bone Spine; 2022 May; 89(3):105296. PubMed ID: 34656752
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.
Coates LC; Gottlieb AB; Merola JF; Boone C; Szumski A; Chhabra A
J Rheumatol; 2019 Feb; 46(2):160-165. PubMed ID: 30323006
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
[TBL] [Abstract][Full Text] [Related]
37. Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression.
Aletaha D; Alasti F; Smolen JS
Ann Rheum Dis; 2017 Feb; 76(2):418-421. PubMed ID: 27457512
[TBL] [Abstract][Full Text] [Related]
38. Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation.
de Agustín JJ; Erra A; Ponce A; Moragues C; Díaz-Torné C; Reina D; Moreno E; Ramírez J; Mateo L; Pujol Busquets M; Moya P; Santo-Panero P; Ros-Expósito S; Narváez J; Sanmartí R; García de Yébenes MJ; Carmona L
Rheumatol Int; 2019 Dec; 39(12):2137-2145. PubMed ID: 31396686
[TBL] [Abstract][Full Text] [Related]
39. Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease.
Helliwell P; Coates LC; FitzGerald O; Nash P; Soriano ER; Elaine Husni M; Hsu MA; Kanik KS; Hendrikx T; Wu J; Kudlacz E
Arthritis Res Ther; 2018 Oct; 20(1):242. PubMed ID: 30373651
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
Chimenti MS; Ortolan A; Lorenzin M; Triggianese P; Talamonti M; Costa L; Caso F; Favero M; Teoli M; Galluzzo M; Scarpa R; Punzi L; Perricone R; Ramonda R
Clin Rheumatol; 2018 Feb; 37(2):397-405. PubMed ID: 29302829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
